Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAESTRAL trial of moxifloxacin versus amoxicillin + clavulanic acid for acute exacerbation of chronic bronchitis
2007-006096-37Phase 4Completed
- Sponsor
- Bayer
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic bronchitis (CB) comparing Moxifloxacin with Amoxicillin + clavulanic acid (2 arms). Primary endpoint: Clinical failure rate at 8 weeks post-therapy. Started Feb 2008; status: completed.
02
Drugs
moxifloxacinamoxicillin + clavulanate
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on 2007-006096-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006096-37.